Author: miracellPH

Miracell Hosts CGP Academy

Miracell Hosts CGP Academy Training Program on Stem Cell-Based Skin Regeneration Techniques [Edaily Reporter Lee Soon-yong] Stem cell specialist Miracell Co., Ltd. (CEO Shin Hyun-soon) held the Cellpia Global Platform Academy (CGP) on the 25th at its headquarters in Yeoksam-dong, Seoul. The lecture focused on “Skin Regeneration Techniques Using Stem Cells.” Dr. Choi Kyung-hee, director of Joo & Clinic and a core member of the CGP and vice president of the Korean Society of Dermatological Plastic Surgery, provided both theoretical and practical training. The Cellpia Global Platform Academy was launched in 2019 by Miracell to promote specialized stem cell treatment and research. It regularly conducts training sessions and shares stem cell medical technology and knowledge through networks with medical professionals at various hospitals and clinics. This CGP Academy focused on skin regeneration techniques using stem cells. Following the theoretical lecture, a Q&A session and discussion,the event concluded with a live stem cell skin regeneration treatment. Director Choi Kyung-hee focused the participants’ attention on the highly anticipated topic of stem cell injections into areas such as the forehead, glabella, under-eye wrinkles, nasolabial folds, and sunken cheeks and neck, focusing on the potential for skin regeneration and the revitalization of youthful skin. This academy was attended by a large number of CGP member directors from regional areas, including Busan and Gwangju, demonstrating the keen interest in stem cell treatment expertise.The stem cells used in skin regeneration treatments at the CGP Academy were extracted using Miracell’s “SMART M-CELL2,”a cutting-edge regenerative medicine biological manufacturing technology that has been certified as a New Health Technology NET (No. 179) by the Ministry of Health and Welfare. Miracell provides a one-stop service encompassing education, technology transfer, medical equipment setup, and marketing to ensure safer stem cell regenerative medicine treatments for hospitals and clinics both domestically and internationally. The GGP membership, with its global reach, is committed to expanding stem cell treatment through technical and academic exchanges with stem cell-specialized hospitals and clinics both domestically and internationally. CEO Shin Hyun-soon stated, “In the future, we plan to create opportunities for Korean CGP member directors to directly participate in international conferences, such as the IMCAS (International Master Course on Aging Science) World Congress, the largest of its kind in Europe, attended by plastic surgeons, dermatologists, and other leading scholars from around the world. We will provide opportunities for Korean CGP member directors to deliver academic lectures on the efficacy and safety of stem cells to European medical professionals.”